Update from the Vaccines and Related Biologics Products Advisory Committee (VRBPAC) Meeting of October 22, 2020

These slides were presented at the ACIP October meeting.

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) reviews and evaluates data concerning the safety, effectiveness, and appropriate use of vaccines and related biological products – VRBPAC is a committee of experts external to FDA that provides input upon request by FDA on certain regulatory actions (e.g., licensure of new vaccines) and on more general topics critical to advancing regulatory science – VRBPAC recommendations are non-binding but usually followed by FDA. The VRBPAC met on October 22, 2020, for a general discussion of the development, authorization and/or licensure of vaccines to prevent COVID-19. This presentation provides feedback on the VRBPAC meeting.